.Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AD03_Melperone.Melperone .Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AD03_Melperone.Melperone| name: | Melperone | |
| ATC code: | N05AD03 | route: | oral |
| compartments: | 1 | |
| dosage: | 50 | mg |
| volume of distribution: | 4.5 | L |
| clearance: | 17 | L/h |
| other parameters in model implementation | ||
Melperone is a butyrophenone antipsychotic drug primarily used for the treatment of schizophrenia and other psychotic disorders. It has a relatively mild side effect profile compared to other antipsychotics. Melperone is not widely available or approved in many countries today, but has been used in Europe, especially Germany.
Estimated pharmacokinetic parameters for adult subjects based on limited published data and general pharmacokinetic principles of butyrophenone antipsychotics. Specific population or condition details not available.
Canal, M, et al., & Santoni, JP (1998). A new oral formulation of tiapride (drops): pharmacokinetic profile and therapeutic applications. Clinical drug investigation 15(5) 455–460. DOI:10.2165/00044011-199815050-00010 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18370501